These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7759081)

  • 1. Eleven novel mutations in the NF2 tumour suppressor gene.
    Bourn D; Evans G; Mason S; Tekes S; Trueman L; Strachan T
    Hum Genet; 1995 May; 95(5):572-4. PubMed ID: 7759081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mutation in the neurofibromatosis type 2 tumor-suppressor gene, giving rise to widely different clinical phenotypes in two unrelated individuals.
    Bourn D; Carter SA; Evans DG; Goodship J; Coakham H; Strachan T
    Am J Hum Genet; 1994 Jul; 55(1):69-73. PubMed ID: 8023853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly polymorphic dinucleotide repeat at the NF2 gene.
    Bourn D; Strachan T
    Hum Genet; 1995 Jun; 95(6):712. PubMed ID: 7789960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA diagnosis of neurofibromatosis 2. Altered coding sequence of the merlin tumor suppressor in an extended pedigree.
    MacCollin M; Mohney T; Trofatter J; Wertelecki W; Ramesh V; Gusella J
    JAMA; 1993 Nov; 270(19):2316-20. PubMed ID: 8230593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline mutations in the neurofibromatosis type 2 tumour suppressor gene.
    Bourn D; Carter SA; Mason S; Gareth D; Evans R; Strachan T
    Hum Mol Genet; 1994 May; 3(5):813-6. PubMed ID: 8081368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CNS Young Investigator Award Lecture: molecular analysis of the neurofibromatosis 2 tumor suppressor.
    MacCollin M
    Brain Dev; 1995; 17(4):231-8. PubMed ID: 7503383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF2 gene in neurofibromatosis type 2 patients.
    Zucman-Rossi J; Legoix P; Der Sarkissian H; Cheret G; Sor F; Bernardi A; Cazes L; Giraud S; Ollagnon E; Lenoir G; Thomas G
    Hum Mol Genet; 1998 Dec; 7(13):2095-101. PubMed ID: 9817927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease.
    Ruttledge MH; Andermann AA; Phelan CM; Claudio JO; Han FY; Chretien N; Rangaratnam S; MacCollin M; Short P; Parry D; Michels V; Riccardi VM; Weksberg R; Kitamura K; Bradburn JM; Hall BD; Propping P; Rouleau GA
    Am J Hum Genet; 1996 Aug; 59(2):331-42. PubMed ID: 8755919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A missense mutation in the neurofibromatosis 2 gene occurs in patients with mild and severe phenotypes.
    Scoles DR; Baser ME; Pulst SM
    Neurology; 1996 Aug; 47(2):544-6. PubMed ID: 8757035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
    Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
    Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetic analysis of the NF2 gene in young patients with unilateral vestibular schwannomas.
    Mohyuddin A; Neary WJ; Wallace A; Wu CL; Purcell S; Reid H; Ramsden RT; Read A; Black G; Evans DG
    J Med Genet; 2002 May; 39(5):315-22. PubMed ID: 12011146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities.
    Parry DM; MacCollin MM; Kaiser-Kupfer MI; Pulaski K; Nicholson HS; Bolesta M; Eldridge R; Gusella JF
    Am J Hum Genet; 1996 Sep; 59(3):529-39. PubMed ID: 8751853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of NF2 germ-line mutations and comparison with neurofibromatosis 2 phenotypes.
    Kluwe L; Bayer S; Baser ME; Hazim W; Haase W; Fünsterer C; Mautner VF
    Hum Genet; 1996 Nov; 98(5):534-8. PubMed ID: 8882871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of patients with neurofibromatosis 2.
    MacCollin M; Ramesh V; Jacoby LB; Louis DN; Rubio MP; Pulaski K; Trofatter JA; Short MP; Bove C; Eldridge R
    Am J Hum Genet; 1994 Aug; 55(2):314-20. PubMed ID: 7913580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of mutations in the NF2 gene in Polish patients with neurofibromatosis type 2.
    Łaniewski-Wołłk M; Gos M; Koziarski A; Szpecht-Potocka A
    J Appl Genet; 2008; 49(3):297-300. PubMed ID: 18670066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic mosaicism: a common cause of classic disease in tumor-prone syndromes? Lessons from type 2 neurofibromatosis.
    Evans DG; Wallace AJ; Wu CL; Trueman L; Ramsden RT; Strachan T
    Am J Hum Genet; 1998 Sep; 63(3):727-36. PubMed ID: 9718334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A missense mutation in the NF2 gene results in moderate and mild clinical phenotypes of neurofibromatosis type 2.
    Kluwe L; Mautner VF
    Hum Genet; 1996 Feb; 97(2):224-7. PubMed ID: 8566958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neurofibromatosis type 2 (NF2)--classical example of a rare familial cancer syndrome].
    Wiszniewski W
    Med Wieku Rozwoj; 1999; 3(1):47-54. PubMed ID: 10910638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
    Kley N; Whaley J; Seizinger BR
    Glia; 1995 Nov; 15(3):297-307. PubMed ID: 8586465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas.
    Sainz J; Huynh DP; Figueroa K; Ragge NK; Baser ME; Pulst SM
    Hum Mol Genet; 1994 Jun; 3(6):885-91. PubMed ID: 7951231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.